AR120358A1 - RECOMBINANT CDKL5 PROTEINS, GENE THERAPY AND PRODUCTION METHODS - Google Patents
RECOMBINANT CDKL5 PROTEINS, GENE THERAPY AND PRODUCTION METHODSInfo
- Publication number
- AR120358A1 AR120358A1 ARP200103015A ARP200103015A AR120358A1 AR 120358 A1 AR120358 A1 AR 120358A1 AR P200103015 A ARP200103015 A AR P200103015A AR P200103015 A ARP200103015 A AR P200103015A AR 120358 A1 AR120358 A1 AR 120358A1
- Authority
- AR
- Argentina
- Prior art keywords
- cdkl5
- recombinant
- gene therapy
- proteins
- production methods
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proveen composiciones para terapia génica con CDKL5, así como también las proteínas CDKL5 recombinantes. Dichas composiciones para terapia génica con CDKL5 y/o proteínas recombinantes pueden incorporar polipéptidos que penetran en la célula y/o polipéptidos señal líder. También se proveen métodos para producir dichas composiciones para terapia génica y proteínas CDKL5 recombinantes, así como también, las composiciones farmacéuticas, métodos de tratamiento y usos de las composiciones de terapia génica y proteínas CDKL5 recombinantes.Compositions for CDKL5 gene therapy are provided, as well as recombinant CDKL5 proteins. Such gene therapy compositions with CDKL5 and/or recombinant proteins may incorporate cell-penetrating polypeptides and/or leader signal polypeptides. Methods for producing such recombinant CDKL5 protein and gene therapy compositions are also provided, as well as pharmaceutical compositions, methods of treatment, and uses of the recombinant CDKL5 protein and gene therapy compositions.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962928134P | 2019-10-30 | 2019-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR120358A1 true AR120358A1 (en) | 2022-02-09 |
Family
ID=80782229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP200103015A AR120358A1 (en) | 2019-10-30 | 2020-10-30 | RECOMBINANT CDKL5 PROTEINS, GENE THERAPY AND PRODUCTION METHODS |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR120358A1 (en) |
-
2020
- 2020-10-30 AR ARP200103015A patent/AR120358A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2022000300A1 (en) | Interleukin 21 muteins and their uses for treating solid tumors (divisional of application no. 202000252) | |
EA201892561A1 (en) | HYBRID PROTEINS GDF15 AND THEIR APPLICATION | |
BR112017018975A2 (en) | fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for il15ra and therapeutic uses thereof. | |
SA518400424B1 (en) | Antibody molecules for cancer treatment | |
BR112021022874A2 (en) | epcam binding proteins and methods of use | |
CO2019002609A2 (en) | Recombinant binding proteins and their uses | |
BR112019001099A2 (en) | uses of extracellular vesicles comprising a fusion protein having fc binding capacity | |
AR115389A1 (en) | CD73 ANTAGONIST ANTIBODY | |
MX2020009371A (en) | Compositions and methods for tcr reprogramming using fusion proteins. | |
PH12020550927A1 (en) | Therapeutic enzyme fusion protein having novel structure and use thereof | |
MX2020005670A (en) | Cdkl5 expression variants and cdkl5 fusion proteins. | |
ECSP22019177A (en) | NKG2D FUSION PROTEINS AND THEIR USES | |
BR112017018538A2 (en) | eukaryotic expression vectors comprising regulatory elements of globin gene clusters | |
DOP2016000079A (en) | RECOMBINANT GLICOPROTEINS AND ITS USES | |
BR112022006842A2 (en) | VARIANT IGF2 CONSTRUCTS | |
BR112022008201A2 (en) | SURFACE PROTEIN DEGRADATION USING B-SPECIFIC BINDING AGENT | |
BR112022003633A2 (en) | Methods for producing recombinant human arginase 1 and uses thereof | |
BR112018077225A2 (en) | tatk-cdkl5 fusion proteins, compositions, formulations and use thereof | |
AR120358A1 (en) | RECOMBINANT CDKL5 PROTEINS, GENE THERAPY AND PRODUCTION METHODS | |
CL2020002507A1 (en) | Variants of lfa3 and compositions and uses thereof | |
BR112022001945A2 (en) | Protein motifs of rubisco binding and uses thereof | |
BR112017005573A2 (en) | solubilized enzyme and its uses | |
AR114938A1 (en) | EXPRESSION VARIANTS OF CDKL5 AND FUSION PROTEINS CDKL5 | |
AR119984A1 (en) | NKG2D FUSION PROTEINS AND THEIR USES | |
WO2021131944A8 (en) | Cancer gene therapy drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |